Free Trial

Femasys (FEMY) Competitors

Femasys logo
$1.11 0.00 (0.00%)
As of 01/17/2025 04:00 PM Eastern

FEMY vs. FONR, GUTS, LNSR, MLSS, MGRM, EDAP, HYPR, VANI, STIM, and NSPR

Should you be buying Femasys stock or one of its competitors? The main competitors of Femasys include FONAR (FONR), Fractyl Health (GUTS), LENSAR (LNSR), Milestone Scientific (MLSS), Monogram Orthopaedics (MGRM), Edap Tms (EDAP), Hyperfine (HYPR), Vivani Medical (VANI), Neuronetics (STIM), and InspireMD (NSPR). These companies are all part of the "medical equipment" industry.

Femasys vs.

FONAR (NASDAQ:FONR) and Femasys (NASDAQ:FEMY) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their risk, media sentiment, community ranking, valuation, earnings, dividends, institutional ownership, profitability and analyst recommendations.

FONAR has higher revenue and earnings than Femasys. Femasys is trading at a lower price-to-earnings ratio than FONAR, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
FONAR$102.88M0.94$10.57M$1.4010.87
Femasys$1.07M23.76-$14.25M-$0.81-1.37

Femasys has a consensus price target of $10.00, indicating a potential upside of 800.90%. Given Femasys' stronger consensus rating and higher possible upside, analysts clearly believe Femasys is more favorable than FONAR.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
FONAR
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Femasys
0 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
3.00

50.6% of FONAR shares are owned by institutional investors. Comparatively, 65.3% of Femasys shares are owned by institutional investors. 2.2% of FONAR shares are owned by company insiders. Comparatively, 12.3% of Femasys shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

FONAR received 149 more outperform votes than Femasys when rated by MarketBeat users. Likewise, 74.69% of users gave FONAR an outperform vote while only 72.09% of users gave Femasys an outperform vote.

CompanyUnderperformOutperform
FONAROutperform Votes
180
74.69%
Underperform Votes
61
25.31%
FemasysOutperform Votes
31
72.09%
Underperform Votes
12
27.91%

FONAR has a net margin of 9.41% compared to Femasys' net margin of -1,435.77%. FONAR's return on equity of 6.10% beat Femasys' return on equity.

Company Net Margins Return on Equity Return on Assets
FONAR9.41% 6.10% 4.58%
Femasys -1,435.77%-141.49%-82.30%

In the previous week, FONAR and FONAR both had 1 articles in the media. FONAR's average media sentiment score of 0.47 beat Femasys' score of 0.33 indicating that FONAR is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
FONAR
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Femasys
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

FONAR has a beta of 1.22, indicating that its share price is 22% more volatile than the S&P 500. Comparatively, Femasys has a beta of -2.82, indicating that its share price is 382% less volatile than the S&P 500.

Summary

FONAR beats Femasys on 11 of the 17 factors compared between the two stocks.

Get Femasys News Delivered to You Automatically

Sign up to receive the latest news and ratings for FEMY and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

FEMY vs. The Competition

MetricFemasysSurgical & medical instruments IndustryMedical SectorNASDAQ Exchange
Market Cap$25.42M$4.71B$5.21B$9.14B
Dividend YieldN/A47.30%5.13%4.02%
P/E Ratio-1.3726.2989.3417.36
Price / Sales23.7658.291,240.0477.11
Price / CashN/A50.1443.7535.97
Price / Book1.317.795.314.79
Net Income-$14.25M$13.87M$122.54M$225.00M
7 Day Performance5.71%1.53%0.59%2.62%
1 Month Performance1.83%10.34%2.55%3.81%
1 Year Performance38.75%32.32%25.29%20.10%

Femasys Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
FEMY
Femasys
3.5841 of 5 stars
$1.11
flat
$10.00
+800.9%
+37.0%$25.42M$1.07M-1.3730
FONR
FONAR
1.32 of 5 stars
$15.13
-0.7%
N/A-20.2%$95.74M$102.01M10.81480Short Interest ↑
News Coverage
GUTS
Fractyl Health
1.6831 of 5 stars
$1.95
+5.4%
$22.00
+1,028.2%
N/A$93.79M$97,000.00-0.16102Short Interest ↑
News Coverage
Positive News
Gap Up
High Trading Volume
LNSR
LENSAR
0.6487 of 5 stars
$8.06
-2.3%
$8.00
-0.7%
+133.1%$93.62M$48.87M-5.52110
MLSS
Milestone Scientific
0.7523 of 5 stars
$1.08
-8.5%
$1.25
+15.7%
+96.7%$84.12M$8.88M-15.4330
MGRM
Monogram Orthopaedics
3.5232 of 5 stars
$2.45
-2.0%
$4.00
+63.3%
-19.2%$84.06M$364,999.00-5.2128Positive News
EDAP
Edap Tms
3.4291 of 5 stars
$2.07
-1.4%
$19.00
+817.9%
-64.5%$76.81M$63.41M-3.18307
HYPR
Hyperfine
2.0021 of 5 stars
$0.98
+4.3%
$1.60
+63.3%
+2.0%$71.49M$13.26M-1.72190
VANI
Vivani Medical
3.4946 of 5 stars
$1.20
-0.8%
$3.00
+150.0%
+17.6%$71.08MN/A-2.6720Positive News
STIM
Neuronetics
3.2663 of 5 stars
$2.34
+36.8%
$4.67
+99.4%
-25.9%$71.01M$72.71M-1.90180Gap Up
High Trading Volume
NSPR
InspireMD
2.1214 of 5 stars
$2.65
-4.0%
$4.75
+79.2%
-13.7%$69.12M$6.82M-3.5350Gap Down

Related Companies and Tools


This page (NASDAQ:FEMY) was last updated on 1/20/2025 by MarketBeat.com Staff
From Our Partners